XNAS
LIEN
Market cap58mUSD
Oct 08, Last price
9.39USD
1D
3.19%
1Q
-4.33%
IPO
-32.93%
Name
Silver Spike Investment Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Silver Spike Investment Corp. (SSIC) functions as both a business development company and a specialized financial entity. Its primary objective is to strategically deploy capital across the rapidly growing cannabis industry by providing direct loans and taking equity positions in privately held cannabis businesses. The firm actively partners with private equity groups, innovators, business owners, and executive teams, offering a spectrum of credit and equity financing options. These solutions are tailored to support various corporate endeavors, including leveraged buyouts, financial reorganizations, expansion initiatives, debt restructuring, and strategic acquisitions within the cannabis ecosystem. This encompasses businesses developing cannabis-enabling technologies, companies focusing on cannabis-related health and wellness products, and enterprises involved in the distribution of hemp and CBD products. Founded in 2021, SSIC is headquartered in New York, New York.
Key people
Scott Gordon
Executive Chairman of the Board, Co-Chief Investment Officer · since 2024
Dino Colonna
President · since 2024
Peter Sack
Chief Executive Officer · since 2025
Alex Woodcock
Chief Compliance Officer · since 2024
Umesh Mahajan
Co-Chief Investment Officer, Secretary · since 2025
Tracey Warson
Lead Independent Director · since 2021
Patrick Mccauley
Director · since 2025
Supurna Vedbrat
Director · since 2025
Vivek Bohra
Independent Director · since 2021
Michael Chorske
Independent Director · since 2021
Americo Da Corte
Independent Director · since 2021
Legal address
C/O CSC-LAWYERS INCORPORATING SERVICE COMPANY
7 ST. PAUL STREET
SUITE 820
BALTIMORE, MD 21202
US
7 ST. PAUL STREET
SUITE 820
BALTIMORE, MD 21202
US
Headquarters
600 Madison Ave Suite 1800
New York, NY 10022
US
New York, NY 10022
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2022‑03 | 2021‑03 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||